Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT00589979

Public ClinicalTrials.gov record NCT00589979. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of the Lidocaine 5% Patch When Used as Adjunct Treatment in Patients With Osteoarthritis of the Knee Receiving Sub-Optimal Pain Relief From Their Current Analgesic Regimen

Study identification

NCT ID
NCT00589979
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Endo USA Inc., a Keenova Therapeutics Company
Industry
Enrollment
169 participants

Conditions and interventions

Interventions

  • Lidoderm (Lidocaine 5% Patch) Drug
  • Placebo Patch Drug

Drug

Eligibility (public fields only)

Age range
37 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2007
Primary completion
May 31, 2008
Completion
Sep 30, 2008
Last update posted
Oct 4, 2017

2007 – 2008

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
Arizona Arthritis Research, PLC Paradise Valley Arizona 85253
NextCare Institute for Clinical Research Phoenix Arizona 85016
HOPE Research Institute, LLC Phoenix Arizona 85050
Clinical Research Consulting Milford Connecticut 06460
New England Research Associates, LLC Trumbull Connecticut 06611
Tampa Bay Medical Research, Inc. Clearwater Florida 33761
Delray Research Associates Delray Beach Florida 33484
CNS Clinical Trials St. Petersburg Florida 33702
Clinical Research of West Florida Tampa Florida 33606
Arthritis & Osteoporosis Center of Maryland Frederick Maryland 21702
Midwest Pharmaceutical Research City of Saint Peters Missouri 63376
Arthritis Center of Nebraska Lincoln Nebraska 68516
Comprehensive Clinical Research Berlin New Jersey 08009
University Hospitals of Case Medical Center - Arthritis Translational Research Program Beachwood Ohio 44122
Community Research Cincinnati Ohio 45245
Health Research of Oklahoma Oklahoma City Oklahoma 73103
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Health Concepts Rapid City South Dakota 57702
Radiant Research San Antonio Texas 78217
Advanced Pain Management & Rehabilitation, Hilltop Medical Virginia Beach Virginia 23454

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00589979, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 4, 2017 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00589979 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →